Characterizing Metabolic Heterogeneity of Hepatocellular Carcinoma with Hyperpolarized C Pyruvate MRI and Mass Spectrometry.

Radiol Imaging Cancer

From the Departments of Radiology (Q.D., A.K.G., M.M., M.A., L.L.T.) and Pathology (I.N.), Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, ANSIN 230, Boston, MA 02215; and Merck & Co, Rahway, NJ (P.C.d.S.).

Published: March 2024

Purpose To characterize the metabolomic profiles of two hepatocellular carcinoma (HCC) rat models, track evolution of these profiles to a stimulated tumor state, and assess their effect on lactate flux with hyperpolarized (HP) carbon 13 (C) MRI. Materials and Methods Forty-three female adult Fischer rats were implanted with N1S1 or McA-RH7777 HCC tumors. In vivo lactate-to-pyruvate ratio (LPR) was measured with HP C MRI at 9.4 T. Ex vivo mass spectrometry was used to measure intratumoral metabolites, and Ki67 labeling was used to quantify proliferation. Tumors were first compared with three normal liver controls. The tumors were then compared with stimulated variants via off-target hepatic thermal ablation treatment. All comparisons were made using the Mann-Whitney test. Results HP C pyruvate MRI showed greater LPR in N1S1 tumors compared with normal liver (mean [SD], 0.564 ± 0.194 vs 0.311 ± 0.057; < .001 [ = 9]), but not for McA-RH7777 ( = .44 [ = 8]). Mass spectrometry confirmed that the glycolysis pathway was increased in N1S1 tumors and decreased in McA-RH7777 tumors. The pentose phosphate pathway was also decreased only in McA-RH7777 tumors. Increased proliferation in stimulated N1S1 tumors corresponded to a net increase in LPR (six stimulated vs six nonstimulated, 0.269 ± 0.148 vs 0.027 ± 0.08; = .009), but not in McA-RH7777 (eight stimulated vs six nonstimulated, = .13), despite increased proliferation and metastases. Mass spectrometry demonstrated relatively increased lactate production with stimulation in N1S1 tumors only. Conclusion Two HCC subtypes showed divergent glycolytic dependency at baseline and during transformation to a high proliferation state. This metabolic heterogeneity in HCC should be considered with use of HP C MRI for diagnosis and tracking. Molecular Imaging-Probe Development, Liver, Abdomen/GI, Oncology, Hepatocellular Carcinoma © RSNA, 2024 See also commentary by Ohliger in this issue.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10988335PMC
http://dx.doi.org/10.1148/rycan.230056DOI Listing

Publication Analysis

Top Keywords

mass spectrometry
16
n1s1 tumors
16
hepatocellular carcinoma
12
tumors compared
12
tumors
9
metabolic heterogeneity
8
pyruvate mri
8
normal liver
8
decreased mca-rh7777
8
mca-rh7777 tumors
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!